POLYTHERAPIE POUR LE TRAITEMENT DU CANCER PAR ADMINISTRATION INTRAVEINEUSE D'UN MVA DE RECOMBINAISON ET D'UN ANTICORPS

• 收藏
• 分享

专利权人:

BAVARIAN NORDIC A/S

发明人:

HOCHREIN, HUBERTUS,LAUTERBACH, HENNING,MEDINA ECHEVERZ, JOSE,HABJAN, MATTHIAS

申请号：

CA3073310

公开号：

CA3073310A1

申请日:

2018.08.23

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The disclosure relates to a pharmaceutical combination consisting of a MVA-TAA (Modified Vaccinia Ankara virus with a tumor-associated antigen) with a second antibody, methods for reducing tumor volume and/or increasing the survival of a cancer patient. The combination further comprises an intravenous administration of a recombinant MVA encoding a tumor-associated antigen and an administration of an antibody to a cancer patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/